[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5415 

# __Development of new drugs and antibodies may not cover all variations of the human coronavirus, leading to gaps in treatment options.__

## Articles mentionning the risk

* [Bayoudhi_overview_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_411.md)

## Mitigations of this risk

* [Continual research and surveillance for emerging variants of the human coronavirus, as well as ongoing development of new drugs and antibodies.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_7288.md)

## Name of the risk

Increased risk of ineffective treatment and failure to address specific strains of the virus.

## People affected by this risk

* [And individuals at risk of human coronavirus infection](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4621.md)

## Stakeholders who can mitigate this risk

* [And public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2693.md)

## Technologies linked to the risk

* [And drug development technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_4871.md)
* [Biomedical research](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6602.md)
* [Genomic sequencing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6603.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

